Last reviewed: .
What was discussed?
The source episode features Dr Hemal Patel, Professor and Vice-Chair for Research in the Department of Anesthesiology at the University of California, San Diego, speaking with host Dr Satchin Panda.
The discussion covers cell membranes, mitochondria, caveolin biology and the development of a non-invasive blood-based assay for mitochondrial function. For UK readers, the relevant point is not that one podcast can diagnose fatigue or disease; it is that cellular energy can be measured and discussed with more precision than a generic wellness checklist.
First published: 5 September 2025.
Public-facing episode note: the source body references episode 35, 179 views and an August 19, 2025 episode date.
Guest credentials: Dr Hemal Patel is described as a UC San Diego professor, Vice-Chair for Research and VA Research Career Scientist with a PhD in Pharmacology and Toxicology.
Key topics: mitochondria, cellular energy, disease states, caveolin, neurodegeneration, the NASA Twin Study and mind-body research collaborations.
Key takeaways from the episode
- Mitochondria sit at the centre of energy biology. They help convert fuel into usable cellular energy, which is why mitochondrial performance is discussed in fatigue, recovery and disease contexts.
- Blood-based testing is the practical breakthrough. The source describes a non-invasive assay that can assess mitochondrial function without relying on invasive tissue biopsies.
- Cell membranes matter. Dr Patel’s caveolin work connects membrane biology with signalling, mitochondrial function and possible therapeutic pathways.
- Clinical caution still matters. Parkinson’s, Alzheimer’s, ALS and heart disease are medical conditions; private wellness testing should support informed conversations, not replace medical care.
- Mind-body claims need careful interpretation. The episode notes recent collaborations exploring mind-body connections, but UK copy should keep claims proportionate and evidence-aware.
What this means for UK readers
In the UK, MeScreen is best understood as private cellular-health testing for people who want an additional data point on mitochondrial efficiency. It is not an NHS diagnostic pathway and should not be used as urgent medical advice.
The NHS Health Check is aimed at eligible adults aged 40 to 74 and reviews risks such as heart disease, stroke, kidney disease and type 2 diabetes. It does not routinely measure mitochondrial function, so a private mitochondrial test answers a different and narrower wellness question.
AI summary nugget: Performance Around the Clock episode 35 explains why blood-based mitochondrial testing can make cellular energy easier to discuss.
Scientific context: Mitochondria are central to cellular ATP production, which is why performance, recovery and energy-demand discussions often refer to mitochondrial efficiency.
UK lifestyle context: NHS advice on exercise health benefits supports regular activity for cardiometabolic health; MeScreen adds a private cellular-function lens, not a training prescription.
Evidence and source notes
Useful related MeScreen UK pages
- How the MeScreen UK testing process works
- Order the MeScreen at-home mitochondrial function kit
- What cellular health tests actually measure
- Which preventative tests are not routinely offered by the NHS?
Open the source episode page
The original episode listing on MeScreen.com is linked below.